|
Neuropathic pain affects approximately 4 million people in the United States each year. Neuropathic pain is associated with many diseases that the primary care clinician encounters every day in his/her practice setting. Diagnosing peripheral neuropathy is often difficult because the symptoms are highly variable. A thorough neurological examination is usually required and involves taking an extensive patient history (including the patient’s symptoms, work environment, social habits, exposure to any toxins, history of alcoholism, risk of HIV or other infectious disease, and family history of neurological disease), performing tests that may identify the cause of the neuropathic disorder, and conducting tests to determine the extent and type of nerve damage.
Learning Objectives
After completing this activity, the participant will be able to:
- Recognize signs and symptoms of neuropathic pain to increase identification of patients with neuropathic pain
- Evaluate available treatment options for neuropathic pain and their appropriateness for your patient population to improve outcomes in these patients
Release date: February 23, 2009
Expiration date: February 23, 2010
Medium: Podcast
Acknowledgement of Commercial Support:
This activity was developed from the live Best Practices in Primary Care™ program held in Anaheim, California on June 13, 2008 which was funded by Endo Pharmaceuticals Inc.
Method of Participation:
To receive CME credit for this activity, you need to listen to the program. Upon finishing the podcast, complete the post-test and evaluation, and fill out all required personal information. To receive your CME certificate you will need to pass the post-test with 70% accuracy or better.
Post-test and Evaluation:
After completing this activity, click on the Post-test button at the end of the program. If you receive less than 70% on the post-test, you will be returned to the beginning of the activity to review the presentation again. Upon successful completion of the post-test, you will be asked to fill out a program evaluation form and prompted to print your CME certificate.
Statement of Disclosure and Independence:
It is the policy of Primary Care Network, Inc. to ensure all its sponsored educational activities are planned, developed, and conducted in accordance with the ACCME’s Essential Areas and Policies. In accordance with ACCME requirements, Primary Care Network has Conflict of Interest and Disclosure Policies that are designed to ensure that Primary Care Network sponsored educational activities are fair balanced, independent, evidence-based and based on scientific rigor.
Primary Care Network’s Resolution of Personal Conflicts of Interest (COI) Policy aims to ensure that all conflicts are resolved prior to the activity, content is developed and presented free of commercial bias, and is in the interest of promoting improvements or quality in healthcare. All individuals who are in a position to influence and/or control content of a Primary Care Network sponsored activity are required to disclose to the participants any real or apparent conflict of interest related to the activity. The educational content is also reviewed for independence and content validation by an independent external clinical reviewer and internal clinical reviewer. Independence is also monitored through the activity and overall program evaluation process.
The opinions, ideas, recommendations, and perspectives expressed in the accompanying presentations at this Primary Care Education program are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Primary Care Network, Primary Care Education, Advisory Boards and Consultants, or the activity’s commercial supporters.
Planning Committee and Disclosures
Charles Argoff, MD
Professor of Neurology & Director
Comprehensive Pain Program
Albany Medical College
Albany, NY
Dr. Argoff receives grant support from Cephalon, Inc. and Endo Pharmaceuticals Inc. He is a member of the speaker’s bureau for Eli Lilly and Company, Endo, King Pharmaceuticals, Inc., Ortho-McNeil, and Pfizer, Inc. Dr. Argoff serves on the advisory boards for Adolor Corporation, Eli Lilly, GlaxoSmithKline, King, Ortho-McNeil, and Pfizer, and is a consultant to Cephalon, Eli Lilly, Endo, NeurogesX, Inc., and Pfizer.
M. Susan Burke, MD, FACP
Director, Lankenau Internal Medicine Clinical Care Center
Wynnewood, Pennsylvania
Clinical Assistant Professor of Medicine
Thomas Jefferson University Medical School
Philadelphia, PA
Dr. Burke is a member of the speaker’s bureau for Boehringer Ingelheim, Merck & Co. Inc., Novartis Pharmaceuticals, Pfizer, Inc., and Schering-Plough Corporation. She serves on the advisory board for Merck and Novartis.
Katherine Galluzzi, DO, CMD, FACOFP, dist
Professor & Chairperson, Department of Geriatrics Medicine
Philadelphia College of Osteopathic Medicine
Philadelphia, PA
Dr. Galluzzi is a member of the speaker’s bureau for Eisai Inc. and Pfizer, Inc. She serves on the advisory boards for Alpharma Inc. and Merck & Co., Inc.
Carol Havens, MD
Director of Clinical Education
Kaiser Permanente
Sacramento, CA
Dr. Havens has no relationships to disclose.
Cynthia Kear
Vice President
External Relations
California Academy of Family Physicians
San Francisco, CA
Ms. Kear has no relationships to disclose.
Rebecca J. Patchin, MD
Assistant Professor of Anesthesiology
Loma Linda University School of Medicine
Loma Linda, CA
Dr. Patchin has no relationships to disclose.
Faculty and Disclosures
Bill McCarberg, MD
Assistant Clinical Professor of Family Medicine
University of San Diego School of Medicine
San Diego, CA
Dr. McCarberg is a member of the speaker’s bureau for Abbott Laboratories, Cephalon, Inc., Eli Lilly and Company, Endo Pharmaceuticals Inc., Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc., and Wyeth Pharmaceuticals.
David E.J. Bazzo, MD, FAAFP
Clinical Professor of Family Medicine
University of San Diego School of Medicine
San Diego, CA
Dr. Bazzo has no relationships to disclose.
Review Committee Disclosure
In accordance with our policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers, staff, and other individuals who control content have no relevant financial relationships to disclose.
Unlabeled Use Declaration:
During their presentation(s), faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.
 Listen to Podcast
When finished, click here to take the Post-test
Take the post-test to receive your CME certificate
|
